Though cannabis remains illegal for recreational purposes, cultivators can be issued licenses for producing fiber and seeds.
In mid-July 2023, the parliament of Ghana approved a bill, the Narcotics Control Commission (Amendment) Bill 2023, to amend previous cannabis legalization in Ghana under certain conditions (1). In recent years, cannabis had been legalized for medical and industrial purposes, yet oversight was placed with the country’s Narcotics Control Board (NACOB) (2). Part of that law was declared unconstitutional by the country’s Supreme Court because it did not include parliamentary debate (2).
With passage of this new amendment to the bill, the Minister of Interior is now authorized to distribute licenses to cultivate cannabis for possible medical and industrial purposes, with a THC limit of .3% (2). Cultivating cannabis for recreational purposes, even with a license, is still illegal (3). The new law did change the prison sentence for simple possession of drugs for recreational use into a fine, however (3).
“The government plans to harness cannabis' vast industrial potential, exploring its applications in fibre and controlled growth seed,” stated Victor Oluwole, Head and Editor at Business Insider Africa (1). “This progressive approach mirrors a broader trend in Africa, as several nations, including Lesotho, Zimbabwe, South Africa, and more, have taken the leap to legalise cannabis for medical and scientific purposes.”
“Despite the optimism surrounding this green revolution, experts emphasise the need to ensure inclusivity for all stakeholders, particularly smallholder farmers,” Oluwole added (1). “It is essential to prevent a situation where corporate giants dominate the industry, leaving ordinary producers struggling to compete.”
Several sources suggest that the new law can open up more opportunities for revival of the agriculture and textile industries in the country (1,2).
References
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.